SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave is receiving significant attention following the announcement of a $3 billion convertible note offering and a 35 million share at-the-market (ATM) program, moves that triggered a sharp sell-off as traders voiced frustration over dilution. Despite the negative market reaction to the financing, discussion remains anchored by the company's recent operational updates, including the deployment of a multi-rack Nvidia Vera Rubin cluster and reports of high-priced customer compute contracts.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

Markets are showing resilience, with indices rebounding in overnight trading following a 25-basis-point Federal Reserve rate hike that market participants largely anticipated. While many traders remain focused on potential future hikes and macroeconomic headwinds, the immediate conversation is driven by the market's recovery and intense debate over whether current price action represents a genuine relief rally or a trap for bears.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is seeing heightened volatility and bullish interest as traders react to a JPMorgan double-upgrade to Overweight with a significantly higher price target, alongside ongoing debates about the company's long-term potential in AI infrastructure and data center capacity. While some investors view recent market turbulence and negative news headlines as temporary hurdles or "fear-mongering" buying opportunities, others remain cautious, citing concerns over dilution, interest rate environments, and broader sector instability.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

The Invesco QQQ Trust is experiencing a relief rally as investors digest the Federal Reserve's decision to hike interest rates by 25 basis points, with many traders viewing the move as already priced into the market. While some participants express caution over a "higher-for-longer" interest rate outlook and macroeconomic headwinds, bullish sentiment persists as many investors emphasize buying the dip and anticipate a continued upward trend in AI-driven tech stocks.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD shares are rebounding as investors dismiss recent speculation about a potential slowdown in AI capital spending as political narrative rather than a shift in fundamental demand. The conversation remains volatile as traders navigate broader market uncertainty ahead of the upcoming Federal Reserve interest rate decision.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

The community is debating the significance of the extended timeline for the Phase 3 REGAL trial, with bulls interpreting the delay as evidence of strong patient survival and bears citing it as a negative indicator of efficacy. Despite persistent speculation and criticism from external observers regarding clinical trial timelines, long-term investors remain bullish, often pointing to institutional accumulation and the potential for a strategic buyout as reasons to maintain their positions.

Space Exploration Technologies Corp., doing business as SpaceX, operates as an aerospace manufacturer, launch service provider, and satellite communications company. It is building the integrated hardware and software infrastructure of the future across space, connectivity, and AI. The firm designs, manufactures, launches, and operates products and services built on cutting-edge technologies, including the rockets and spacecraft. The company was founded by Elon Reeve Musk in 2002 and is headquartered in Starbase, TX.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

SpaceX is trending as investors remain focused on strong institutional demand, potential AI-computing growth, and the upcoming Starship launch, despite ongoing volatility from Fed rate-hike concerns and chatter regarding share lockup expirations. Market participants are debating whether the stock's recent performance signals a sustainable breakout or a bull trap, with many closely watching the price level around $155 for further momentum.

CleanSpark, Inc. is a bitcoin mining technology company, which engages in the management of data centers. Its operations include College Park, Norcross, Washington, Sandersville, Dalton, and Massena. The company was founded by S. Matthew Schultz and Bryan Huber on October 15, 1987 and is headquartered in Henderson, NV.

Cleanspark Inc

CleanSpark is trending as investors react to a significant Bitcoin price surge and the broader AI data center sector, while debate continues over the company's valuation, high short interest, and the status of its ongoing infrastructure build-outs. Sentiment remains polarized between bulls anticipating a short squeeze or re-rating based on Bitcoin holdings and data center deal potential, and bears expressing frustration over the stock's recent performance compared to its peers.

Snap, Inc. is a technology company, which engages in the provision of a visual messaging application that was created to help people communicate through short videos and images. The company was founded by Frank Reginald Brown IV, Evan Thomas Spiegel, and Robert C. Murphy in 2010 and is headquartered in Santa Monica, CA.

Snap Inc - Ordinary Shares - Class A

Snap Inc

Snap Inc. is trending as investors react to the company's unveiling of its new 'Specs Intelligence' AI assistant and AR smart glasses. While some traders are expressing optimism over these new product integrations and potential enterprise applications, others remain skeptical, citing the glasses' high price point, ongoing litigation, and concerns regarding management's history of stock-based compensation.

Fluence Energy, Inc. engages in energy storage products and services, and artificial intelligence-enabled digital applications for renewables and storage. Its storage includes Smartstack, Gridstack Pro, Grisdtack, and Ultrastack. The company was founded on June 21, 2021, and is headquartered in Arlington, VA.

Fluence Energy Inc - Ordinary Shares - Class A

Fluence Energy shares are experiencing extreme volatility following a guidance cut for fiscal 2026, which the company attributed to production ramp-up delays at its Houston manufacturing facility. While the community is sharply divided between those viewing the pullback as a buying opportunity given the strong order backlog and those concerned about management's execution and liquidity, trading volume has surged amid speculation of a potential short squeeze.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Kyverna Therapeutics is trending as investors focus on upcoming clinical trial data readouts and the progress of its BLA submission for its lead CAR T-cell therapy, miv-cel. Community discussion is characterized by high conviction in the company's differentiated safety profile and potential for acquisition, with many traders debating valuation compared to peers despite ongoing market volatility.

Kyverna Therapeutics vs. Vertex Pharmaceuticals: Which Drug Developer Stock Is a Better Buy in 2026?

Key PointsKyverna Therapeutics is a clinical-stage biopharmaceutical firm advancing cell therapies for autoimmune diseases...

Kyverna Therapeutics Names Greg Martini CFO

(RTTNews) - Kyverna Therapeutics, Inc. (KYTX), Monday announced the appointment of Greg Martini as Chief Financial Officer, effective May 18...

Kyverna Therapeutics, Inc. (NASDAQ:KYTX) Receives Consensus Recommendation of "Moderate Buy" from Analysts

Shares of Kyverna Therapeutics, Inc. (NASDAQ:KYTX - Get Free Report) have received an average rating of 'Moderate Buy' from the five research firms that are covering the company, Marketbeat Ratings...

Kyverna Therapeutics (KYTX) to Release Earnings on Tuesday

Kyverna Therapeutics (NASDAQ:KYTX) will be releasing its Q1 2026 earnings before the market opens on Tuesday, May 12. (View Earnings Report at...

AIGH Capital Management LLC Acquires Shares of 1,500,000 Kyverna Therapeutics, Inc. $KYTX

AIGH Capital Management LLC purchased a new stake in shares of Kyverna Therapeutics, Inc. (NASDAQ:KYTX - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 1,500,000 shares of the company's stock, valued at approximately...

Kyverna Therapeutics Showcases miv-cel Data in SPS, gMG; CEO Eyes First Autoimmune CAR-T BLA

Kyverna Therapeutics (NASDAQ:KYTX) highlighted new clinical data for its CD19-directed autologous CAR T-cell therapy mivocabtagene autoleucel (miv-cel), formerly KYV-101, during an American Academy of Neurology (AAN) conference call focused on stiff person syndrome (SPS) and generalized myasthenia g...

Peapod Lane Capital LLC Decreases Holdings in Kyverna Therapeutics, Inc. $KYTX

Peapod Lane Capital LLC decreased its position in Kyverna Therapeutics, Inc. (NASDAQ:KYTX - Free Report) by 42.3% during the 4th quarter, according to its most recent disclosure with the SEC. The...

Kyverna Therapeutics' (KYTX) "Buy" Rating Reiterated at HC Wainwright

HC Wainwright restated a "buy" rating and set a $20.00 price target on shares of Kyverna Therapeutics in a research note on Thursday...

Kyverna Therapeutics (NASDAQ:KYTX) Shares Gap Up   - Should You Buy?

Kyverna Therapeutics (NASDAQ:KYTX) Shares Gap Up - Should You Buy...

Why Kyverna Therapeutics Shares Are Trading Higher By Over 25%; Here Are 20 Stocks Moving Premarket

Kyverna Therapeutics Inc (NASDAQ: KYTX) shares rose 25.8% in pre-market trading after positive trial results for miv-cel. Other gainers include HCAI, ELPW, and ALP.read more...

Kyverna Therapeutics, Inc. is a cell therapy clinical-stage biotechnology company, which engages in the provision of treatments and potential cures for serious autoimmune diseases. The company was founded in June 2018 and is headquartered in Emeryville, CA.

Kyverna Therapeutics Inc.

Dow, Nasdaq, S&P 500 Futures Edge Higher After Trump Extends Iran Ceasefire: POET, NVTS, KYTX, TSLA Stocks Garner Focus Today

Equity

Bearish Sentiment

A - Strong, decisive leadership

B - Solid, but room to improve

C - Mixed, still figuring it out

D/F - Poor communication and execution

Kevin Warsh has served as Federal Reserve Chair since May 2026, following one of the most divisive Senate confirmations in Fed history, and just delivered the Fed's first rate hike since 2023. How do you grade Kevin Warsh's performance as Fed chair so far? Vote and explain your reasoning in the comments.

Kevin Warsh has been Fed chair since May. How do you grade his performance so far?

Current Price	$6.90
Prev Close	$6.96
Open	$7.02
Dividend Yield	0.00%
50-Day Moving Average	$7.97
Beta	1.96
Avg. Volume	670,229.68
PE Ratio	-2.35

52-Week High	$13.67
52-Week Low	$4.40
Market Capitalization	$426.72M
EPS (Annual)	-$3.64
Price to Book	2.57
Revenue Per Employee	$0.00

Feed

News

Sentiment

Earnings

Fundamentals

Info

KYTX Fundamentals